CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting

Contributed by: Business Wire

Tags

Health

Surgery

Genetics

Managed Care

General Health

Cardiology

Biotechnology

CareDx, Inc.

More Like This

CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting

CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients

Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025

International Research Collaboration Aims to Personalise Prevention and Treatment of Cardiovascular Diseases

Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025

PR Newswire associated0

Caristo to Unveil New Clinical and Research Results at SCCT 2025

Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026

Alnylam to Present Detailed Results from the HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress 2024